Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation.1985;71:510-515.
Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying
the population at risk. Vasc Med.1997;2:221-226.
Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vasc Biol.1998;18:185-192.
Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic
peripheral arterial disease in the general population. Int J Epidemiol.1991;20:384-392.
Hirsch AT, Halverson SL, Treat-Jacobson D.
et al. The Minnesota Regional Peripheral Arterial Disease Screening Program:
toward a definition of community standards of care. Vasc Med.2001;6:87-96.
Fowkes FGR. Epidemiology of peripheral vascular disease. Atherosclerosis.1997;131(suppl):S29-S31.
Papademetriou V, Narayan P, Rubins H, Collins D, Robins S.for the HIT Investigators. Influence of risk factors on peripheral and cerebrovascular disease
in men with coronary artery disease, low high-density lipoprotein cholesterol
levels, and desirable low-density lipoprotein cholesterol levels. Am Heart J.1998;136:734-740.
Ouriel K, McDonnell AE, Metz CE, Zarins CK. Critical evaluation of stress testing in the diagnosis of peripheral
vascular disease. Surgery.1982;91:686-693.
Yao ST, Hobbs JT, Irvine WT. Ankle systolic pressure measurements in arterial disease affecting
the lower extremities. Br J Surg.1969;56:676-679.
Criqui MH, Denenberg JO, Bird CE, Fronek A, Klauber MR, Langer RD. The correlation between symptoms and non-invasive test results in patients
referred for peripheral arterial disease testing. Vasc Med.1996;1:65-71.
Ansell BJ, Watson KE, Fogelman AM. An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines:
National Cholesterol Education Program. JAMA.1999;282:2051-2057.
Executive Summary of the Third Report of the National Cholesterol Education
Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High
Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA.2001;285:2486-2497.
Downs JR, Clearfield M, Weis S.
et al. Primary prevention of acute coronary events with lovastatin in men
and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air
Force/Texas Coronary Atherosclerosis Prevention Study. JAMA.1998;279:1615-1622.
American Heart Association. Fact Sheet on Heart Attack, Stroke and Risk Factors. Dallas, Tex: American Heart Association; 1999. Publication. 55-0532
99 18 D.
Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership. Take Steps Against Peripheral Arterial Disease. New York, NY; Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership;
Department of Health and Human Services, Food and Drug Administration. Internal analgesic, antipyretic, and antirheumatic drug products for
over-the-counter human use; final rule for professional labeling of aspirin,
buffered aspirin, and aspirin in combination with antacid drug products [21
CFR Part 343]. Federal Register.1998;63:56802-56819.
Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society
Consensus (TASC). J Vasc Surg.2000;31(1 pt 2):S1-S296.
Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial
disease, and atherothrombotic brain infarction in men and women 62 years of
age. Am J Cardiol.1994;74:64-65.
Kannel WB, Skinner JJJ, Schwartz MJ, Shurtleff D. Intermittent claudication. Incidence in the Framingham Study. Circulation.1970;41:875-883.
Newman AB, Sutton-Tyrrell K, Rutan GH, Locher J, Kuller LH. Lower extremity arterial disease in elderly patients with systolic
hypertension. J Clin Epidemiol.1991;44:15-20.
Newman AB, Siscovick DS, Manolio TA.
et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular
Health Study. Circulation.1993;88:837-845.
Newman AB, Tyrrell KS, Kuller LH. Mortality over four years in SHEP participants with a low ankle-arm
index. J Am Geriatr Soc.1997;45:1472-1478.
McDermott MM. Ankle brachial index as a predictor of outcomes in peripheral arterial
disease. J Lab Clin Med.1999;133:33-40.
McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor
of mortality. Atherosclerosis.1991;87:119-128.
McDermott MM, Mehta S, Ahn H, Greenland P. Atherosclerotic risk factors are less intensively treated in patients
with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med.1997;12:209-215.
Jonason T, Bergstrom R. Cessation of smoking in patients with intermittent claudication: effects
on the risk of peripheral vascular complications, myocardial infarction and
mortality. Acta Med Scand.1987;221:253-260.
Hirsch AT, Treat-Jacobson D, Lando HA, Hatsukami DK. The role of tobacco cessation, anti-platelet, and lipid-lowering therapies
for the treatment of peripheral arterial disease. Vasc Med.1997;2:243-251.
Hulley S, Grady D, Bush T.
et al. Randomized trial of estrogen plus progestin for secondary prevention
of coronary heart disease in postmenopausal women. JAMA.1998;280:605-613.
Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure. Arch Intern Med.1997;157:2413-2446. [published erratum appears in Arch Intern Med. 1998;158:573].
Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy,
I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet
therapy in various categories of patients. BMJ.1994;308:81-106.
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel vs aspirin in patients
at risk of ischaemic events (CAPRIE). Lancet.1996;348:1329-1339.
Jackson MR, Clagett GP. Antithrombotic therapy in peripheral arterial occlusive disease. Chest.1998;114(suppl 5):666S-682S.
Braunwald E, Antman EM, Beasley JW.
et al. ACC/AHA guidelines for the management of patients with unstable angina
and non-ST-segment elevation myocardial infarction. A report of the American
College of Cardiology/American Heart Association Task Force on Practice Guidelines
(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol.2000;36:970-1062.
Criqui MH, Langer RD, Fronek A.
et al. Mortality over a period of 10 years in patients with peripheral arterial
disease. N Engl J Med.1992;326:381-386.
Newman AB, Shemanski L, Manolio TA.
et al. Ankle-arm index as a predictor of cardiovascular disease and mortality
in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol.1999;19:538-545.
Vogt MT, Cauley JA, Newman AB, Kuller LH, Hulley SB. Decreased ankle/arm blood pressure index and mortality in elderly women. JAMA.1993;270:465-469.
Zheng ZJ, Sharrett AR, Chambless LE.
et al. Associations of ankle-brachial index with clinical coronary heart disease,
stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis
Risk in Communities (ARIC) Study. Atherosclerosis.1997;131:115-125.